Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-03-24A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties Using Contrast Enhanced Ultrasound in High-Risk Women Using Fenretinide (4-HPR)
-
CLINICAL_TRIALS study record update · 2010-03-17Phase II Trial of Fulvestrant in Treatment of Recurrent Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2010-03-02A Pilot, Phase II, Single Center, Non-comparative, Open-label Study of Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2010-02-26Phase II Open Label Study of CT-2106 as a Single Agent in Patients With Advanced Metastatic Ovarian Cancer Who Have Failed One Prior Platinum and Taxane Based Regimen
-
CLINICAL_TRIALS study record update · 2010-02-24ERCC1 Expression as a Predictor of Progression Free and Overall Survival in Patients With Epithelial Ovarian Cancer Treated on GOG Protocols 0172 and 0182
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-02-22A Phase 2 Study of XL999 Administered Intravenously to Subjects With Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2010-02-09Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis
-
CLINICAL_TRIALS study record update · 2010-02-08A Phase II Study of Carboplatin and Paclitaxel as Neoadjuvant Chemotherapy Followed by Interval Cytoreduction in Women With Advanced Staged Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma for High-Risk Surgical Candidates or Patients Unlikely to be Optimally Surgically Cytoreduced
-
CLINICAL_TRIALS study record update · 2010-02-03A Phase II Randomized Study of Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)
-
CLINICAL_TRIALS study record update · 2010-02-01A Pilot Study Using the Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
-
CLINICAL_TRIALS study record update · 2010-01-27Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial
-
CLINICAL_TRIALS study record update · 2010-01-13PHASE I STUDY OF TAXOTERE IN PATIENTS WITH ADVANCED MALIGNANCIES AND VARYING DEGREES OF LIVER DYSFUNCTION
-
CLINICAL_TRIALS study record update · 2010-01-07Evaluating Tools for Health Promotion and Disease Prevention
-
CLINICAL_TRIALS study record update · 2009-12-15A Phase I Trial of Lapatinib in Combination With Carboplatin in Patients With Platinum Sensitive Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2009-11-26An Open-Label, Single-Arm, Phase II Study of IV Weekly (Days 1 and 8 Every 21 Days) HYCAMTIN in Combination With Carboplatin (Day 1 Every 21 Days) as Second-Line Therapy in Subjects With Potentially Platinum-Sensitive Relapsed Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2009-11-13A Prospective Study of The Prevalence and Significance of Paraneoplastic Autoantibodies in Small Cell Lung Cancer and Cancer of The Breast, Ovary, Hodgkin's Disease, Neuroblastoma and Other Cancers
-
CLINICAL_TRIALS study record update · 2009-09-25Phase II Study of 852A Administered Subcutaneously in Patients With Metastatic Refractory Breast, Ovarian, Endometrial and Cervical Cancers
-
CLINICAL_TRIALS study record update · 2009-09-24A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2009-08-24A Phase II Evaluation of Pemetrexed (Alimta, LY231514l, IND # 40061) in the Treatment of Recurrent or Persistent Platinum Resistant Ovarian or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2009-07-29Systematic Nutritional Care in Patients Receiving First-line Chemotherapy for Metastatic Gynecologic Cancer in a Phase II Study
-
CLINICAL_TRIALS study record update · 2009-07-20Genetic Studies in Breast Cancer
-
CLINICAL_TRIALS study record update · 2009-07-14An Open Label, Phase 2 Study of Biweekly VELCADE and Intermittent CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
-
CLINICAL_TRIALS study record update · 2009-06-04A Phase IIA Evaluation of Safety and Efficacy of Weekly S-8184 Paclitaxel Injectable Emulsion in Second Line Treatment of Stage III or IV Platinum Resistant Ovarian Cancer or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2009-05-18A Phase II Study of Weekly Docetaxel and Capecitabine for Persistent or Recurrent Platinum Resistant Epithelial Carcinoma of the Ovary, Fallopian Tube or Peritoneum
-
CLINICAL_TRIALS study record update · 2009-04-30A Phase I-II Trial of Mild Whole-Body Hyperthermia Combined With Liposomal Doxorubicin/5-Fluorouracil in Patients With Advanced Malignancy